Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith W Muir

Showing results (11-20 of 258) with videos related to

Pageof 26
Sort By:
Stroke|December 7, 2002
Inflammation, blood pressure, and stroke: an opportunity to target primary prevention?Keith W Muir
Neurochemistry International|September 14, 2016
Clinical trial design for stem cell therapies in stroke: What have we learned?Keith W Muir
The Lancet. Neurology|September 8, 2012
Imaging and treatment response after ischaemic strokeKeith W Muir
Stroke|May 10, 2022
Current State and Future for Emerging Stroke Therapies: Reflections and ReactionsKeith W Muir, Gustavo Saposnik
Neurology|May 26, 2004
Journey of an embolusAileen McGonigal, Keith W Muir
Practical Neurology|May 26, 2010
Set up and run a thrombolysis service for acute strokeKeith W Muir, Tracey Baird
Stem Cells and Cloning : Advances and Applications|March 15, 2014
Brain repair: cell therapy in strokeDheeraj Kalladka, Keith W Muir
Current Treatment Options in Neurology|August 15, 2022
Tenecteplase or Alteplase: What Is the Thrombolytic Agent of the Future?Ammad Mahmood, Keith W Muir
Neurochemistry International|April 2, 2011
Stem cell therapy in stroke: designing clinical trialsDheeraj Kalladka, Keith W Muir
Lancet (London, England)|February 23, 2016
HERMES: messenger for stroke interventional treatmentKeith W Muir, Philip White
Pageof 26

Showing results (11-20 of 258) with videos related to

Sort By:
Pageof 26
Stroke|December 7, 2002
Inflammation, blood pressure, and stroke: an opportunity to target primary prevention?Keith W Muir
Neurochemistry International|September 14, 2016
Clinical trial design for stem cell therapies in stroke: What have we learned?Keith W Muir
The Lancet. Neurology|September 8, 2012
Imaging and treatment response after ischaemic strokeKeith W Muir
Stroke|May 10, 2022
Current State and Future for Emerging Stroke Therapies: Reflections and ReactionsKeith W Muir, Gustavo Saposnik
Neurology|May 26, 2004
Journey of an embolusAileen McGonigal, Keith W Muir
Practical Neurology|May 26, 2010
Set up and run a thrombolysis service for acute strokeKeith W Muir, Tracey Baird
Stem Cells and Cloning : Advances and Applications|March 15, 2014
Brain repair: cell therapy in strokeDheeraj Kalladka, Keith W Muir
Current Treatment Options in Neurology|August 15, 2022
Tenecteplase or Alteplase: What Is the Thrombolytic Agent of the Future?Ammad Mahmood, Keith W Muir
Neurochemistry International|April 2, 2011
Stem cell therapy in stroke: designing clinical trialsDheeraj Kalladka, Keith W Muir
Lancet (London, England)|February 23, 2016
HERMES: messenger for stroke interventional treatmentKeith W Muir, Philip White
Pageof 26